Predicate |
Object |
contentType |
Comparative Study|Journal Article|Review |
endingPage |
705 |
issn |
1368-5031 |
issueIdentifier |
7 |
pageRange |
695-705 |
publicationName |
International Journal of Clinical Practice |
startingPage |
695 |
bibliographicCitation |
Balbisi EA. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. Int J Clin Pract. 2004 Jul;58(7):695–705. doi: 10.1111/j.1368-5031.2004.00218.x. PMID: 15311727. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_baaeca1777ad4f9e60b633f236ae18ff |
date |
2004-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.1111/j.1368-5031.2004.00218.x https://pubmed.ncbi.nlm.nih.gov/15311727 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20688 https://portal.issn.org/resource/ISSN/1368-5031 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine |
discusses |
http://id.nlm.nih.gov/mesh/M0281019 http://id.nlm.nih.gov/mesh/M0022087 http://id.nlm.nih.gov/mesh/M0003337 http://id.nlm.nih.gov/mesh/M0026371 http://id.nlm.nih.gov/mesh/M0027392 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8804 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7706 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9653 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77992 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f674fd7cea07c51978185af7f56ffc06 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152944 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bc9cbdf4b4cd1dcbc8bfcd12a341d8b8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8494 |